ad/pnp
Biologicalexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 11, 2019 (NCT03754933)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03754933 | Phase 1/Phase 2 (Phase 2) | Feb 11, 2019 | Emory University, Food and Drug Administration, PNP Therapeutics, Inc., Stanford University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Food and Drug Administration | Government | 1 | 0 | 1 | 2019 |
| PNP Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2019 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2019 |
4 organizations
Page 1 / 1